These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34603678)

  • 21. Synthesis of dimeric ADP-ribose and its structure with human poly(ADP-ribose) glycohydrolase.
    Lambrecht MJ; Brichacek M; Barkauskaite E; Ariza A; Ahel I; Hergenrother PJ
    J Am Chem Soc; 2015 Mar; 137(10):3558-64. PubMed ID: 25706250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poly(ADP-ribose): From chemical synthesis to drug design.
    Drenichev MS; Mikhailov SN
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3395-403. PubMed ID: 27318540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ADPr-Peptide Synthesis.
    Kistemaker HAV; Voorneveld J; Filippov DV
    Methods Mol Biol; 2018; 1813():345-369. PubMed ID: 30097880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A family of macrodomain proteins reverses cellular mono-ADP-ribosylation.
    Jankevicius G; Hassler M; Golia B; Rybin V; Zacharias M; Timinszky G; Ladurner AG
    Nat Struct Mol Biol; 2013 Apr; 20(4):508-14. PubMed ID: 23474712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poly(ADP-ribosyl)ation directs recruitment and activation of an ATP-dependent chromatin remodeler.
    Gottschalk AJ; Timinszky G; Kong SE; Jin J; Cai Y; Swanson SK; Washburn MP; Florens L; Ladurner AG; Conaway JW; Conaway RC
    Proc Natl Acad Sci U S A; 2009 Aug; 106(33):13770-4. PubMed ID: 19666485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Processing of protein ADP-ribosylation by Nudix hydrolases.
    Palazzo L; Thomas B; Jemth AS; Colby T; Leidecker O; Feijs KL; Zaja R; Loseva O; Puigvert JC; Matic I; Helleday T; Ahel I
    Biochem J; 2015 Jun; 468(2):293-301. PubMed ID: 25789582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ADP-ribose-specific chromatin-affinity purification for investigating genome-wide or locus-specific chromatin ADP-ribosylation.
    Bisceglie L; Bartolomei G; Hottiger MO
    Nat Protoc; 2017 Sep; 12(9):1951-1961. PubMed ID: 28837130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation and Characterization of Recombinant Antibody-like ADP-Ribose Binding Proteins.
    Gibson BA; Conrad LB; Huang D; Kraus WL
    Biochemistry; 2017 Dec; 56(48):6305-6316. PubMed ID: 29053245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ADP-ribosyl-binding and hydrolase activities of the alphavirus nsP3 macrodomain are critical for initiation of virus replication.
    Abraham R; Hauer D; McPherson RL; Utt A; Kirby IT; Cohen MS; Merits A; Leung AKL; Griffin DE
    Proc Natl Acad Sci U S A; 2018 Oct; 115(44):E10457-E10466. PubMed ID: 30322911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PARP2 mediates branched poly ADP-ribosylation in response to DNA damage.
    Chen Q; Kassab MA; Dantzer F; Yu X
    Nat Commun; 2018 Aug; 9(1):3233. PubMed ID: 30104678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reading ADP-ribosylation signaling using chemical biology and interaction proteomics.
    Kliza KW; Liu Q; Roosenboom LWM; Jansen PWTC; Filippov DV; Vermeulen M
    Mol Cell; 2021 Nov; 81(21):4552-4567.e8. PubMed ID: 34551281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered cytoplasmic and nuclear ADP-ribosylation levels analyzed with an improved ADP-ribose binder are a prognostic factor in renal cell carcinoma.
    Schraml P; Aimi F; Zoche M; Aguilera-Garcia D; Arnold F; Moch H; Hottiger MO
    J Pathol Clin Res; 2023 Jul; 9(4):273-284. PubMed ID: 36999983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tripartite Motif-containing 33 (TRIM33) protein functions in the poly(ADP-ribose) polymerase (PARP)-dependent DNA damage response through interaction with Amplified in Liver Cancer 1 (ALC1) protein.
    Kulkarni A; Oza J; Yao M; Sohail H; Ginjala V; Tomas-Loba A; Horejsi Z; Tan AR; Boulton SJ; Ganesan S
    J Biol Chem; 2013 Nov; 288(45):32357-32369. PubMed ID: 23926104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Tools for the Study of ADP-Ribosylation: A Unified and Versatile Method to Synthesise Native Mono-ADP-Ribosylated Peptides.
    Voorneveld J; Rack JGM; van Gijlswijk L; Meeuwenoord NJ; Liu Q; Overkleeft HS; van der Marel GA; Ahel I; Filippov DV
    Chemistry; 2021 Jul; 27(41):10621-10627. PubMed ID: 33769608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ENPP1 processes protein ADP-ribosylation in vitro.
    Palazzo L; Daniels CM; Nettleship JE; Rahman N; McPherson RL; Ong SE; Kato K; Nureki O; Leung AK; Ahel I
    FEBS J; 2016 Sep; 283(18):3371-88. PubMed ID: 27406238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromatin remodeler ALC1 prevents replication-fork collapse by slowing fork progression.
    Ooka M; Abe T; Cho K; Koike K; Takeda S; Hirota K
    PLoS One; 2018; 13(2):e0192421. PubMed ID: 29408941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping Physiological ADP-Ribosylation Using Activated Ion Electron Transfer Dissociation.
    Buch-Larsen SC; Hendriks IA; Lodge JM; Rykær M; Furtwängler B; Shishkova E; Westphall MS; Coon JJ; Nielsen ML
    Cell Rep; 2020 Sep; 32(12):108176. PubMed ID: 32966781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ADP-Ribosylation as Post-Translational Modification of Proteins: Use of Inhibitors in Cancer Control.
    Poltronieri P; Miwa M; Masutani M
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical Tools to Study Protein ADP-Ribosylation.
    van der Heden van Noort GJ
    ACS Omega; 2020 Feb; 5(4):1743-1751. PubMed ID: 32039309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The chromatin remodeler ALC1 underlies resistance to PARP inhibitor treatment.
    Juhász S; Smith R; Schauer T; Spekhardt D; Mamar H; Zentout S; Chapuis C; Huet S; Timinszky G
    Sci Adv; 2020 Dec; 6(51):. PubMed ID: 33355125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.